OpenVSafe by OpenVAERS
Search V-safe

8DX-32223-04089

3 vaccinations 4 coded responses 26 check-ins 4 free-text entries 2 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
853 / AZ
Registered
2021-01-11
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-11
    Registered in v-safe
  2. 2021-01-11
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-11
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-12
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site mass — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea
    Free text: Small lump at injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tiredness
    Adult check-in
  6. 2021-01-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness
    Adult check-in
  7. 2021-01-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Swelling, Itching · Fatigue or tiredness
    Adult check-in
  8. 2021-01-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Swelling, Itching · None
    Adult check-in
  9. 2021-01-18
    Health check-in — day 7, dose 1
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  10. 2021-01-25
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-01
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-03
    Dose 2 — Pfizer-BioNTech
  13. 2021-02-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  14. 2021-02-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  15. 2021-02-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-02-07
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site bruising — Feeling: Good
    Free text: Injection site is not red or painful, but is bruised
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-10
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-02-17
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-24
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-03
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-10
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-17
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-05-05
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-08-04
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-12-01
    Dose 3 — Pfizer-BioNTech
  28. 2022-02-05
    Health check-in — 12 months, dose 2
    Feeling: Fair
    Adult check-in
  29. 2022-06-01
    Survey response — 6 months, dose 3
    MedDRA: Inflammatory marker increased, Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Common cold symptoms currently (ongoing since 11 days ago), have tested neg twice for COVID. Also have had ongoing elevation of inflammation markers for several months.
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-06-01
    Report sent to call center — 6 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  31. 2022-06-02
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  32. 2022-12-01
    Survey response — 12 months, dose 3
    MedDRA: COVID-19, Colon operation, Diverticulitis, Hospitalisation, Hypothyroidism, Large intestine perforation, Menopause, Psoriatic arthropathy, Sepsis, Sinusitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: I currently have COVID. I had a bad sinus infection. I was also hospitalized for sepsis secondary to colon perforation/diverticulitis, with resultsnt colon resection. Diagnosed with psoriatic arthritis and hypothyroidism as well as menopause.
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-12-01
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  34. 2022-12-02
  35. 2022-12-08
  36. 2022-12-08
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-01-11Pfizer-BioNTech
22021-02-03Pfizer-BioNTech
32021-12-01Pfizer-BioNTech No

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-12

Systemic reaction (other): Small lump at injection site

Release 3 — days 1–6 daily, dose 2

2021-02-07

Systemic reaction (other): Injection site is not red or painful, but is bruised

Release 11 — 6 months, dose 3

2022-06-01

Symptoms: Common cold symptoms currently (ongoing since 11 days ago), have tested neg twice for COVID. Also have had ongoing elevation of inflammation markers for several months.

Release 12 — 12 months, dose 3

2022-12-01

Symptoms: I currently have COVID. I had a bad sinus infection. I was also hospitalized for sepsis secondary to colon perforation/diverticulitis, with resultsnt colon resection. Diagnosed with psoriatic arthritis and hypothyroidism as well as menopause.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDColon operation · · ✓
SDCOVID-19 · · ✓
SDDiverticulitis · · ✓
SDHospitalisation · · ✓
SDHypothyroidism · · ✓
SDInflammatory marker increased · · ✓
SDLarge intestine perforation · · ✓
SDMenopause · · ✓
SDNasopharyngitis · · ✓
SDPsoriatic arthropathy · · ✓
SDSARS-CoV-2 test negative · · ✓
SDSepsis · · ✓
SDSinusitis · · ✓
SROInjection site bruising ✓ ✓ ✓
SROInjection site mass ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release